Sera Prognostics, Inc.SERA

NasdaqHealthcareServices-Medical Laboratories
Price (close)
$2.11
Market cap
$83.2M
P/E
—
Revenue (TTM)
$70,000
Net income
-$33.2M
Dividend yield
—
1-year total return
-28.5%
Net margin
-47475.7%
Revenue growth
-35.2%
Debt / equity
—

What Sera Prognostics, Inc. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$25,000$82,000$268,000$306,000$77,000$81,000
Net income-$19.8M-$35.0M-$44.2M-$36.2M-$32.9M-$31.9M
Free cash flow-$17.0M-$32.9M-$35.4M-$27.3M-$14.2M-$26.3M

More on SERA.

Figures from Sera Prognostics, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.